Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1152 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
NPJ5008 for treating malignant hyperthermia	NPJ5008	Malignant hyperthermia	Genetic Disorders	2022	View \| Download
NVK-002 for myopia in children	NVK-002	Myopia	Ophthalmology	2023	View \| Download
NY-ESO-1 T cells for the treatment of synovial sarcoma	NY-ESO-1c259-modified SPEAR T Cells (GSK3377794)	Soft tissue sarcoma	Sarcoma	2017	View \| Download
Obecabtagene autoleucel for treating refractory or relapsed B cell acute lymphoblastic leukaemia	Obecabtagene autoleucel	Acute lymphoblastic leukaemia (ALL)	Haematological Cancer and Lymphomas	2023	View \| Download
Obeticholic acid for non-alcoholic steatohepatitis and fibrosis	Obeticholic Acid (Ocaliva; INT-747)	Non-alcoholic steatohepatitis (NASH)	Hepatology	2019	View \| Download
Obinutuzumab with mycophenolate mofetil for treating lupus nephritis	Mycophenolate mofetil (Cellcept) , Obinutuzumab (Gazyvaro; RO5072759; GA101; Afutuzumab)	Lupus nephritis	Immunology , Nephrology	2023	View \| Download
Ocrelizumab (subcutaneous) for the treatment of primary progressive or relapsing multiple sclerosis	Ocrelizumab (Ocrevus;2H7v114)	Multiple sclerosis (MS)	Neurology	2023	View \| Download
Odevixibat for cholestatic liver disease in Alagille syndrome patients	Odevixibat (A4250)	Alagille syndrome	Genetic Disorders	2022	View \| Download
Odevixibat for treating biliary atresia in children following Kasai hepatoportoenterostomy	Odevixibat (A4250)	Biliary atresia	Hepatology	2024	View \| Download
Ofatumumab for relapsing multiple sclerosis	Ofatumumab (Arzerra)	Multiple sclerosis (MS)	Neurology	2019	View \| Download